Preserving Geriatric Muscle With an Osteoporosis Medication
Status:
Recruiting
Trial end date:
2028-04-01
Target enrollment:
Participant gender:
Summary
Our goal is to demonstrate efficacy of the novel agent Denosumab to improve or preserve
muscle health, strength, mobility and function in frail older adults.